Selective Pancreatic Stenting and Rectal Indomethacin in High-Risk ERCP Patients Results in Significant Decrease in Post-Ercp Pancreatitis

HPB - United Kingdom
doi 10.1016/j.hpb.2018.02.032
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Rectal Indomethacin for the Prevention of Post-Ercp Pancreatitis

Gastroenterology
HepatologyGastroenterology
2016English

A Randomized Trial of Rectal Indomethacin to Prevent Post-Ercp Pancreatitis

New England Journal of Medicine
Medicine
2012English

Risk Factors for Post-Ercp Pancreatitis in High Risk Patients Who Have Undergone Prophylactic Pancreatic Duct Stenting: A Multicenter Retrospective Study

Internal Medicine
Internal MedicineMedicine
2011English

ERCP in Babies: Low Risk of Post-Ercp Pancreatitis – Results From a Multicentre Survey

United European Gastroenterology Journal
OncologyGastroenterology
2019English

Reduced Risk of Post ERCP Pancreatitis in Statin Users

BMC Gastroenterology
MedicineGastroenterology
2020English

How to Select Patients and Timing for Rectal Indomethacin to Prevent Post-Ercp Pancreatitis: A Systematic Review and Meta-Analysis

BMC Gastroenterology
MedicineGastroenterology
2017English

Post-Ercp Pancreatitis: Risk Factors and Role of NSAIDs in Primary Prophylaxis

Pakistan Journal of Medical Sciences
Medicine
2020English

Is the Laparoscopic Cholecystectomy Feasible in Patients With Post-Ercp Pancreatitis?

HPB
HepatologyGastroenterology
2016English

Systematic Review: Periprocedural Hydration in the Prevention of Post-Ercp Pancreatitis

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy